Headline News about Bristol-Myers Squibb
FDA To Review Two Cell Therapies For Multiple Myeloma This Week - Johnson & Johnson And Bristol-Myers
March 13, 2024
Via Benzinga
Exposures
Product Safety
Via Benzinga
Via Benzinga
Bristol-Myers Squibb's Options Frenzy: What You Need to Know
March 04, 2024
Via Benzinga
A Closer Look at Bristol-Myers Squibb's Options Market Dynamics
February 22, 2024
Via Benzinga
How Is The Market Feeling About Bristol-Myers Squibb?
February 21, 2024
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
March 04, 2024
Via Benzinga
Unpacking the Latest Options Trading Trends in Bristol-Myers Squibb
February 09, 2024
Via Benzinga
Top Cannabis Appointments You Should Know About: Aurora's New CFO And Other Changes
February 20, 2024
Via Benzinga
Topics
Cannabis
Exposures
Cannabis
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.